Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Primary Amyloidosis”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Early research (Phase 1)Active Not RecruitingNCT03283917
What this trial is testing

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Who this might be right for
Newly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis
M.D. Anderson Cancer Center 21
Not applicableLooking for participantsNCT06455748
What this trial is testing

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

Who this might be right for
Amyloid Light-chain Amyloidosis
Yongyong MA 20
Testing effectiveness (Phase 2)Looking for participantsNCT07638683
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

Who this might be right for
Multiple MyelomaAL Amyloidosis
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01194791
What this trial is testing

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed

Who this might be right for
Primary Systemic Amyloidosis
PETHEMA Foundation 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055724
What this trial is testing

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

Who this might be right for
AL Amyloidosis
Nanjing IASO Biotechnology Co., Ltd. 17
Testing effectiveness (Phase 2)Study completedNCT00621400
What this trial is testing

Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis

Who this might be right for
Amyloidosis
Nantes University Hospital 27
Not applicableStudy completedNCT03401372
What this trial is testing

BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients

Who this might be right for
Amyloidosis; Systemic
Jian Li 140
Large-scale testing (Phase 3)Ended earlyNCT03474458
What this trial is testing

A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy

Who this might be right for
Cardiac AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 19
Testing effectiveness (Phase 2)Study completedNCT03236792
What this trial is testing

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Icahn School of Medicine at Mount Sinai 28
Testing effectiveness (Phase 2)Looking for participantsNCT06629818
What this trial is testing

Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)

Who this might be right for
Light Chain (AL) Amyloidosis
Peking Union Medical College Hospital 36
Testing effectiveness (Phase 2)Study completedNCT00981708
What this trial is testing

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

Who this might be right for
Amyloidosis
University of Athens 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996406
What this trial is testing

Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)

Who this might be right for
Light Chain (AL) AmyloidosisCCND1 TranslocationVenetoclax
Peking Union Medical College Hospital 36
Early research (Phase 1)Ended earlyNCT01807286
What this trial is testing

Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT00898066
What this trial is testing

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous/Nonmalignant Condition
SWOG Cancer Research Network 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224672
What this trial is testing

Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

Who this might be right for
Amyloidosis
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT03201965
What this trial is testing

Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Amyloidosis
Janssen Research & Development, LLC 416
Large-scale testing (Phase 3)Looking for participantsNCT06022939
What this trial is testing

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
SWOG Cancer Research Network 338
Not applicableLooking for participantsNCT06376214
What this trial is testing

Daratumumab for Patients With Light Chain Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Nanjing University School of Medicine 100
Testing effectiveness (Phase 2)Looking for participantsNCT07079423
What this trial is testing

Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis

Who this might be right for
AL Amyloidosis
Peking Union Medical College Hospital 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524634
What this trial is testing

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

Who this might be right for
Amyloid Light-chain Amyloidosis
Case Comprehensive Cancer Center 64
Load More Results